- Home
- ACRV vs MNY Comparison
ACRV vs MNY Comparison
Compare ACRV & MNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- MNY
- Stock Information
- Founded
- ACRV 2018
- MNY 2014
- Country
- ACRV United States
- MNY Singapore
- Employees
- ACRV N/A
- MNY N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- MNY
- Sector
- ACRV Health Care
- MNY
- Exchange
- ACRV Nasdaq
- MNY Nasdaq
- Market Cap
- ACRV 41.7M
- MNY 43.9M
- IPO Year
- ACRV 2022
- MNY N/A
- Fundamental
- Price
- ACRV $1.33
- MNY $1.84
- Analyst Decision
- ACRV Buy
- MNY Strong Buy
- Analyst Count
- ACRV 7
- MNY 1
- Target Price
- ACRV $17.40
- MNY $4.00
- AVG Volume (30 Days)
- ACRV 213.8K
- MNY 166.9K
- Earning Date
- ACRV 08-13-2025
- MNY 09-18-2025
- Dividend Yield
- ACRV N/A
- MNY N/A
- EPS Growth
- ACRV N/A
- MNY N/A
- EPS
- ACRV N/A
- MNY N/A
- Revenue
- ACRV N/A
- MNY $71,649,746.00
- Revenue This Year
- ACRV N/A
- MNY $16.97
- Revenue Next Year
- ACRV $1,037.93
- MNY $19.35
- P/E Ratio
- ACRV N/A
- MNY N/A
- Revenue Growth
- ACRV N/A
- MNY N/A
- 52 Week Low
- ACRV $1.05
- MNY $0.55
- 52 Week High
- ACRV $10.16
- MNY $2.15
- Technical
- Relative Strength Index (RSI)
- ACRV 51.00
- MNY 55.75
- Support Level
- ACRV $1.27
- MNY $1.68
- Resistance Level
- ACRV $1.42
- MNY $2.06
- Average True Range (ATR)
- ACRV 0.08
- MNY 0.19
- MACD
- ACRV 0.00
- MNY -0.04
- Stochastic Oscillator
- ACRV 55.32
- MNY 50.00
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.